Cypre invited to present at Tumor Models SF

Kolin presents Cypre's case studies in translational oncology research and debuts Cypre's platform technology for 3D cell models and ex vivo research, VersaGel™ and Symphony™, arriving end of March.

In attendance, scientists and clinicians from top pharmaceuticals, CROs, and cancer centers including Merck, Genentech, Amgen, Celgene, Takeda, MD Anderson, Jackson Laboratory, Crown Bio, Champions Oncology, MI Bioresearch, and Cedars Sinai.

More information:


Tumor Models SF,

Tumor Models SF,

IMG_0627 (3).jpg
Kolin Hribar